<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mancarella S</submitter><funding>Ministero della Salute</funding><funding>Fondazione AIRC per la ricerca sul cancro ETS</funding><pagination>286</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11484308</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cancer-associated fibroblasts (CAFs), mainly responsible for the desmoplastic reaction hallmark of intrahepatic Cholangiocarcinoma (iCCA), likely have a role in tumor aggressiveness and resistance to therapy, although the molecular mechanisms involved are unknown. Aim of the study is to investigate how targeting hCAF/iCCA cross-talk with a Notch1 inhibitor, namely Crenigacestat, may affect cancer progression.&lt;h4>Methods&lt;/h4>We used different in vitro models in 2D and established new 3D hetero-spheroids with iCCA cells and human (h)CAFs. The results were confirmed in a xenograft model, and explanted tumoral tissues underwent transcriptomic and bioinformatic analysis.&lt;h4>Results&lt;/h4>hCAFs/iCCA cross-talk sustains increased migration of both KKU-M213 and KKU-M156 cells, whi</pubmed_abstract><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pubmed_title>Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest.</pubmed_title><pmcid>PMC11484308</pmcid><funding_grant_id>Ricerca Corrente 2024</funding_grant_id><funding_grant_id>IG 2020 ID 24815</funding_grant_id><pubmed_authors>Pizzuto E</pubmed_authors><pubmed_authors>De Bellis M</pubmed_authors><pubmed_authors>Ardito F</pubmed_authors><pubmed_authors>Terzi A</pubmed_authors><pubmed_authors>Dituri F</pubmed_authors><pubmed_authors>Vincenti L</pubmed_authors><pubmed_authors>Maiorano E</pubmed_authors><pubmed_authors>Mancarella S</pubmed_authors><pubmed_authors>Serino G</pubmed_authors><pubmed_authors>Calvisi DF</pubmed_authors><pubmed_authors>Giannelli G</pubmed_authors><pubmed_authors>Gigante I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest.</name><description>&lt;h4>Background&lt;/h4>Cancer-associated fibroblasts (CAFs), mainly responsible for the desmoplastic reaction hallmark of intrahepatic Cholangiocarcinoma (iCCA), likely have a role in tumor aggressiveness and resistance to therapy, although the molecular mechanisms involved are unknown. Aim of the study is to investigate how targeting hCAF/iCCA cross-talk with a Notch1 inhibitor, namely Crenigacestat, may affect cancer progression.&lt;h4>Methods&lt;/h4>We used different in vitro models in 2D and established new 3D hetero-spheroids with iCCA cells and human (h)CAFs. The results were confirmed in a xenograft model, and explanted tumoral tissues underwent transcriptomic and bioinformatic analysis.&lt;h4>Results&lt;/h4>hCAFs/iCCA cross-talk sustains increased migration of both KKU-M213 and KKU-M156 cells, whi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-04-30T00:05:56.247Z</modification><creation>2025-04-06T14:23:23.378Z</creation></dates><accession>S-EPMC11484308</accession><cross_references><pubmed>39415286</pubmed><doi>10.1186/s13046-024-03210-9</doi></cross_references></HashMap>